162 results
Page 4 of 9
8-K
EX-99.1
k0b9pga0vxfu11
11 Feb 21
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
4vz9 jth4li72tslxq
11 Jan 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
qpii0re13r3r
17 Nov 20
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
7:15am
8-K
EX-99.2
5ww1b7ecmz wnw6
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
zwfhhwp
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
cwujxw5 7p
9 Oct 20
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
5:20pm
8-K
un1vlee7kv4xu
9 Oct 20
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
5:20pm
8-K
EX-99.2
3dzqc5i11119j 6ehvw
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
8-K
EX-99.1
a8o28
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
8-K
EX-99.1
su1zk0s24ngw39w
13 Feb 20
Results of Operations and Financial Condition
7:06am
8-K
EX-99.1
z1xr24b6
13 Jan 20
Regulation FD Disclosure
7:07am
8-K
bfr3 h3r4262iwu5
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-99.1
m0du wg4dyk
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-2.1
gvmw3t ulpqh2env
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-99.1
jt83hggu oukn
18 Nov 19
Alkermes to Acquire Rodin Therapeutics
7:16am